ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-13C13054
Home | Market Reports
Global Gene Therapy Sales Market Report 2023
BUY CHAPTERS

Global Gene Therapy Market Research Report 2026

Code: QYRE-Auto-13C13054
Report
2026-02-03
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Akcea Therapeutics
Bluebird bio
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Roche
CSL Behring
BioMarin Pharmaceutical

Gene Therapy Market Size

The global Gene Therapy market was valued at US$ 14330 million in 2025 and is anticipated to reach US$ 77240 million by 2032, at a CAGR of 27.6% from 2026 to 2032.

Gene Therapy Market

Gene Therapy Market

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.
Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
This report delivers a comprehensive overview of the global Gene Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Therapy. The Gene Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Gene Therapy Market Report

Report Metric Details
Report Name Gene Therapy Market
Accounted market size in 2025 US$ 14330 million
Forecasted market size in 2032 US$ 77240 million
CAGR 27.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Viral Gene Therapy
  • Non-Viral Gene Therapy
Segment by Application
  • Neurological Diseases
  • Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Roche, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute, CSL Behring, BioMarin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Gene Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Gene Therapy Market growing?

Ans: The Gene Therapy Market witnessing a CAGR of 27.6% during the forecast period 2026-2032.

What is the Gene Therapy Market size in 2032?

Ans: The Gene Therapy Market size in 2032 will be US$ 77240 million.

What is the market share of major companies in Gene Therapy Market?

Ans: Global top three manufacturers hold a share about 75%.

Who are the main players in the Gene Therapy Market report?

Ans: The main players in the Gene Therapy Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Roche, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute, CSL Behring, BioMarin Pharmaceutical

What are the Application segmentation covered in the Gene Therapy Market report?

Ans: The Applications covered in the Gene Therapy Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene Therapy Market report?

Ans: The Types covered in the Gene Therapy Market report are Viral Gene Therapy, Non-Viral Gene Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2021–2032)
2.2 Global Gene Therapy Growth Trends by Region
2.2.1 Global Gene Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Therapy Historic Market Size by Region (2021–2026)
2.2.3 Gene Therapy Forecasted Market Size by Region (2027–2032)
2.3 Gene Therapy Market Dynamics
2.3.1 Gene Therapy Industry Trends
2.3.2 Gene Therapy Market Drivers
2.3.3 Gene Therapy Market Challenges
2.3.4 Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Revenue
3.1.1 Global Top Gene Therapy Players by Revenue (2021–2026)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2025
3.5 Global Key Players of Gene Therapy Head Offices and Areas Served
3.6 Global Key Players of Gene Therapy, Products and Applications
3.7 Global Key Players of Gene Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2021–2026)
4.2 Global Gene Therapy Forecasted Market Size by Type (2027–2032)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2021–2026)
5.2 Global Gene Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Therapy Market Size (2021–2032)
6.2 North America Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Therapy Market Size by Country (2021–2026)
6.4 North America Gene Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Market Size (2021–2032)
7.2 Europe Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Therapy Market Size by Country (2021–2026)
7.4 Europe Gene Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Market Size (2021–2032)
8.2 Asia-Pacific Gene Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Therapy Market Size (2021–2032)
9.2 Latin America Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Therapy Market Size by Country (2021–2026)
9.4 Latin America Gene Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Market Size (2021–2032)
10.2 Middle East & Africa Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy Introduction
11.1.4 Biogen Revenue in Gene Therapy Business (2021–2026)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy Introduction
11.2.4 Novartis Revenue in Gene Therapy Business (2021–2026)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2021–2026)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2021–2026)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2021–2026)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy Introduction
11.6.4 Amgen Revenue in Gene Therapy Business (2021–2026)
11.6.5 Amgen Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Gene Therapy Introduction
11.7.4 Roche Revenue in Gene Therapy Business (2021–2026)
11.7.5 Roche Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2021–2026)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Gene Therapy Business (2021–2026)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2021–2026)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Gene Therapy Business (2021–2026)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy Introduction
11.12.4 AnGes Revenue in Gene Therapy Business (2021–2026)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2021–2026)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2021–2026)
11.14.5 Human Stem Cells Institute Recent Development
11.15 CSL Behring
11.15.1 CSL Behring Company Details
11.15.2 CSL Behring Business Overview
11.15.3 CSL Behring Gene Therapy Introduction
11.15.4 CSL Behring Revenue in Gene Therapy Business (2021–2026)
11.15.5 CSL Behring Recent Development
11.16 BioMarin Pharmaceutical
11.16.1 BioMarin Pharmaceutical Company Details
11.16.2 BioMarin Pharmaceutical Business Overview
11.16.3 BioMarin Pharmaceutical Gene Therapy Introduction
11.16.4 BioMarin Pharmaceutical Revenue in Gene Therapy Business (2021–2026)
11.16.5 BioMarin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Akcea Therapeutics
Bluebird bio
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Roche
CSL Behring
BioMarin Pharmaceutical
List of Tables
 Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Viral Gene Therapy
 Table 3. Key Players of Non-Viral Gene Therapy
 Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Gene Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Gene Therapy Market Share by Region (2021–2026)
 Table 8. Global Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Gene Therapy Market Share by Region (2027–2032)
 Table 10. Gene Therapy Market Trends
 Table 11. Gene Therapy Market Drivers
 Table 12. Gene Therapy Market Challenges
 Table 13. Gene Therapy Market Restraints
 Table 14. Global Gene Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Gene Therapy Market Share by Players (2021–2026)
 Table 16. Global Top Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Therapy Revenue, 2025
 Table 17. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Gene Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Gene Therapy, Products and Applications
 Table 21. Global Key Players of Gene Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Gene Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Gene Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Gene Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global Gene Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Gene Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Gene Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Gene Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Gene Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Gene Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Gene Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Gene Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Gene Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Gene Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Gene Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Gene Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Gene Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. Biogen Company Details
 Table 47. Biogen Business Overview
 Table 48. Biogen Gene Therapy Product
 Table 49. Biogen Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 50. Biogen Recent Development
 Table 51. Novartis Company Details
 Table 52. Novartis Business Overview
 Table 53. Novartis Gene Therapy Product
 Table 54. Novartis Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 55. Novartis Recent Development
 Table 56. Gilead Sciences Company Details
 Table 57. Gilead Sciences Business Overview
 Table 58. Gilead Sciences Gene Therapy Product
 Table 59. Gilead Sciences Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 60. Gilead Sciences Recent Development
 Table 61. Sarepta Therapeutics Company Details
 Table 62. Sarepta Therapeutics Business Overview
 Table 63. Sarepta Therapeutics Gene Therapy Product
 Table 64. Sarepta Therapeutics Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 65. Sarepta Therapeutics Recent Development
 Table 66. Alnylam Pharmaceuticals Company Details
 Table 67. Alnylam Pharmaceuticals Business Overview
 Table 68. Alnylam Pharmaceuticals Gene Therapy Product
 Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 70. Alnylam Pharmaceuticals Recent Development
 Table 71. Amgen Company Details
 Table 72. Amgen Business Overview
 Table 73. Amgen Gene Therapy Product
 Table 74. Amgen Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 75. Amgen Recent Development
 Table 76. Roche Company Details
 Table 77. Roche Business Overview
 Table 78. Roche Gene Therapy Product
 Table 79. Roche Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 80. Roche Recent Development
 Table 81. Akcea Therapeutics Company Details
 Table 82. Akcea Therapeutics Business Overview
 Table 83. Akcea Therapeutics Gene Therapy Product
 Table 84. Akcea Therapeutics Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 85. Akcea Therapeutics Recent Development
 Table 86. bluebird bio Company Details
 Table 87. bluebird bio Business Overview
 Table 88. bluebird bio Gene Therapy Product
 Table 89. bluebird bio Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 90. bluebird bio Recent Development
 Table 91. Sunway Biotech Company Details
 Table 92. Sunway Biotech Business Overview
 Table 93. Sunway Biotech Gene Therapy Product
 Table 94. Sunway Biotech Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 95. Sunway Biotech Recent Development
 Table 96. SIBIONO Company Details
 Table 97. SIBIONO Business Overview
 Table 98. SIBIONO Gene Therapy Product
 Table 99. SIBIONO Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 100. SIBIONO Recent Development
 Table 101. AnGes Company Details
 Table 102. AnGes Business Overview
 Table 103. AnGes Gene Therapy Product
 Table 104. AnGes Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 105. AnGes Recent Development
 Table 106. Orchard Therapeutics Company Details
 Table 107. Orchard Therapeutics Business Overview
 Table 108. Orchard Therapeutics Gene Therapy Product
 Table 109. Orchard Therapeutics Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 110. Orchard Therapeutics Recent Development
 Table 111. Human Stem Cells Institute Company Details
 Table 112. Human Stem Cells Institute Business Overview
 Table 113. Human Stem Cells Institute Gene Therapy Product
 Table 114. Human Stem Cells Institute Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 115. Human Stem Cells Institute Recent Development
 Table 116. CSL Behring Company Details
 Table 117. CSL Behring Business Overview
 Table 118. CSL Behring Gene Therapy Product
 Table 119. CSL Behring Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 120. CSL Behring Recent Development
 Table 121. BioMarin Pharmaceutical Company Details
 Table 122. BioMarin Pharmaceutical Business Overview
 Table 123. BioMarin Pharmaceutical Gene Therapy Product
 Table 124. BioMarin Pharmaceutical Revenue in Gene Therapy Business (US$ Million), 2021–2026
 Table 125. BioMarin Pharmaceutical Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Gene Therapy Picture
 Figure 2. Global Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Gene Therapy Market Share by Type: 2025 vs 2032
 Figure 4. Viral Gene Therapy Features
 Figure 5. Non-Viral Gene Therapy Features
 Figure 6. Global Gene Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Gene Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Neurological Diseases Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Other Case Studies
 Figure 11. Gene Therapy Report Years Considered
 Figure 12. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Gene Therapy Market Share by Region: 2025 vs 2032
 Figure 15. Global Gene Therapy Market Share by Players in 2025
 Figure 16. Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2025
 Figure 18. North America Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Gene Therapy Market Share by Country (2021–2032)
 Figure 20. United States Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Gene Therapy Market Share by Country (2021–2032)
 Figure 24. Germany Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Gene Therapy Market Share by Region (2021–2032)
 Figure 32. China Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Gene Therapy Market Share by Country (2021–2032)
 Figure 40. Mexico Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Gene Therapy Market Share by Country (2021–2032)
 Figure 44. Israel Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Biogen Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 48. Novartis Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 49. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 52. Amgen Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 53. Roche Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 55. bluebird bio Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 56. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 57. SIBIONO Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 58. AnGes Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 59. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 60. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 61. CSL Behring Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 62. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Business (2021–2026)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Gene Transplant Market Research Report 2024
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Delivery or Gene Therapy Drug Market Research Report 2025
Global Gene based Therapy Medicinal Market Research Report 2024
Global Human Gene Therapy Market Research Report 2025
Global Gene based Advanced Therapy Medicinal Market Research Report 2025
Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapy For Cancer Market Research Report 2024
Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell and Gene Therapy Market Research Report 2024
Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Gene Therapy On Cardiovascular Disease Market Research Report 2025
Global Gene Therapy for CNS Disorders Market Research Report 2024
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions